CNBC August 29, 2023
Key Points
– Two blood thinners and a diabetes medication are the most widely used by Medicare enrollees among a list of 10 drugs that will be subject to price negotiations between manufacturers and Medicare.
– Bristol-Myers Squibb’s blood thinner Eliquis was the most used among Medicare enrollees, with 3.7 million beneficiaries using it.
– The Biden administration unveiled the much-awaited list, officially kicking off a process that aims to control rising drug costs in the U.S.
Two blood thinners and a diabetes medication are the drugs most widely used by Medicare beneficiaries among a list of 10 drugs that will be subject to price negotiations between manufacturers and Medicare.
The Biden administration unveiled the much-awaited list Tuesday,...
Today's Sponsors
Today's Sponsor